June 14, 2021 Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients
June 14, 2021 ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease
June 12, 2021 Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
June 11, 2021 Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
June 10, 2021 A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome
June 10, 2021 Neurofilament light chain as a biomarker of meningoencephalitis of unknown etiology in dogs
June 9, 2021 The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): The Study Protocol for an 18-Month, Multicenter, Randomized, Controlled Trial
June 9, 2021 Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations